8-KEarnings & ResultsExhibits & Filings

THERMO FISHER SCIENTIFIC INC. 8-K Report, Financial Results (Jan 31, 2024)

Filed January 31, 2024For Securities:TMO

Summary

Thermo Fisher Scientific Inc. (TMO) has filed an 8-K report on January 31, 2024, to announce its financial results for the fiscal quarter and full year ended December 31, 2023. The key details of these results are provided in a press release furnished as Exhibit 99.1 to this filing. Investors should review this press release for specific figures related to revenue, earnings, and other financial performance indicators. While this 8-K filing itself is primarily a notification of the earnings release, it directs investors to the accompanying press release for comprehensive financial data. This includes information on the company's operational performance, financial condition, and likely forward-looking statements or guidance. Investors are advised to access Exhibit 99.1 for a detailed understanding of TMO's performance during the reported periods and any implications for future financial trends.

Key Highlights

  • 1Thermo Fisher Scientific (TMO) announced its financial results for the fourth quarter and full fiscal year ended December 31, 2023.
  • 2The financial results were disclosed via a press release furnished as Exhibit 99.1 to the 8-K filing.
  • 3Investors are directed to Exhibit 99.1 for detailed information on the company's performance.
  • 4The filing's primary purpose is to report the earnings release event.
  • 5Information contained within this 8-K and its exhibits is furnished, not deemed 'filed' under Section 18 of the Exchange Act, unless expressly incorporated by reference into a specific filing.
  • 6The filing date is January 30, 2024, with the event date also being January 30, 2024.

Frequently Asked Questions

The specific financial results are detailed in the press release furnished as Exhibit 99.1 to this 8-K filing. Investors should refer to this exhibit for comprehensive data.

This 8-K filing's main significance is to formally announce Thermo Fisher Scientific's earnings release for the fourth quarter and full year 2023. It serves as a gateway to the detailed financial performance information contained in the accompanying press release.

No, the information contained in this 8-K filing and its exhibits is furnished. It is not considered 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934 or subject to the liabilities of that section, unless specifically incorporated by reference into another filing.